Results 11 to 20 of about 224,268 (252)
In the 2019 European Society of Cardiology guidelines, chronic coronary syndrome (CCS) was introduced as a new term for stable coronary artery disease. Diagnosis, treatment and prevention of CCS have undergone major changes. In the diagnostic management of CCS, there is increased focus on non-invasive imaging modalities, including coronary CT ...
Tine Glavind Bülow, Pedersen +5 more
+6 more sources
Coronary Magnetic Resonance Angiography in Chronic Coronary Syndromes [PDF]
Cardiovascular disease is the leading cause of mortality worldwide, with atherosclerotic coronary artery disease (CAD) accounting for the majority of cases. X-ray coronary angiography and computed tomography coronary angiography (CCTA) are the imaging modalities of choice for the assessment of CAD.
Reza Hajhosseiny +10 more
openaire +4 more sources
Gut Microbiome in Chronic Coronary Syndrome Patients [PDF]
Despite knowledge of classical coronary artery disease (CAD) risk factors, the morbidity and mortality associated with this disease remain high. Therefore, new factors that may affect the development of CAD, such as the gut microbiome, are extensively investigated.
Emilia Sawicka-Smiarowska +30 more
openaire +3 more sources
Management of Chronic Coronary Syndrome: 2024 Update. [PDF]
Xie Y, Jiang J, Wang J.
europepmc +4 more sources
Colchicine for acute and chronic coronary syndromes [PDF]
Colchicine is an ancient drug, traditionally used for the treatment and prevention of gouty attacks; it has become standard of treatment for pericarditis with a potential role in the treatment of coronary artery disease. Atherosclerotic plaque formation, progression, destabilisation and rupture are influenced by active proinflammatory cytokines ...
Massimo Imazio +4 more
openaire +3 more sources
Layered plaque in patients with chronic coronary syndrome. [PDF]
Plaque disruption exposes thrombogenic substrates and triggers local thrombosis. When a fresh thrombus forms, endogenous antithrombotic mechanisms activate. The balance between these two pro- and antithrombotic mechanisms determines the outcome of plaque disruption. When thrombogenic stimuli outweigh the antithrombotic mechanisms, an occlusive thrombus
Mito T +11 more
europepmc +4 more sources
The Incremental Role of Coronary Computed Tomography in Chronic Coronary Syndromes [PDF]
In the context of chronic coronary syndromes (CCS), coronary computed tomography angiography (CCTA) has gained broad acceptance as a noninvasive anatomical imaging tool with ability of excluding coronary stenosis with strong negative predictive value.
Francesca Baessato +12 more
openaire +4 more sources
Chronic coronary syndrome with suspected Takayasu's arteritis. [PDF]
Złahoda-Huzior A +6 more
europepmc +4 more sources
The Role of Uric Acid in Acute and Chronic Coronary Syndromes [PDF]
Uric acid (UA) is the final product of the catabolism of endogenous and exogenous purine nucleotides. While its association with articular gout and kidney disease has been known for a long time, new data have demonstrated that UA is also related to cardiovascular (CV) diseases.
Alessandro Maloberti +16 more
openaire +4 more sources
Inflammatory response to elective percutaneous coronary intervention is related to myocardial injury [PDF]
Introduction: In acute coronary syndrome, the release of inflammatory and myocardial injury biomarkers after percutaneous coronary intervention is associated with poor prognosis.
Priscilla Teixeira Céo Frisso +10 more
doaj +1 more source

